Featured Research

from universities, journals, and other organizations

Occupational sunlight exposure reduces kidney cancer risk in men, study suggests

Date:
March 8, 2010
Source:
American Cancer Society
Summary:
Study says men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work.

According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women.

Published early online in Cancer the study is the largest case-control study of kidney cancer to investigate the association with occupational sunlight exposure. The study, however, did not include information on non-occupational sunlight exposure and does not address directly whether sunlight exposure can help prevent kidney cancer.

Research suggests that vitamin D, which is obtained from sun exposure, some foods, and from supplements, may help prevent some cancers. Vitamin D is metabolized and most active within the kidneys. Because both the incidence of kidney cancer and the prevalence of vitamin D deficiency have increased over the past few decades, Sara Karami, PhD, of the National Cancer Institute in Rockville, MD, and her colleagues designed a study to explore whether occupational sunlight exposure is associated with kidney cancer risk.

The study included 1,097 patients with kidney cancer and 1,476 individuals without cancer from four Central and Eastern European countries. Demographic and lifetime occupational information was collected through in-person interviews and occupational sunlight exposure indices were estimated based on industry and job titles. The investigators observed a 24 percent to 38 percent reduction in kidney cancer risk with increasing occupational sunlight exposure among male participants in the study. No association between occupational sunlight exposure and kidney cancer risk was observed among females in the study.

The findings suggest that sunlight exposure may affect kidney cancer risk, although the authors have no explanation for the apparent differences in risk between men and women. They offer several hypotheses for the observed differences. Biological or behavioral differences between men and women may play a role. For example, hormonal differences may influence the body's response to sunlight exposure, females may have a higher tendency to use sunscreen on a regular basis, and men may be prone to working outdoors while shirtless. It is also possible that the observed gender differences in risk were due to confounding by other unmeasured kidney cancer risk factors, such as recreational sunlight exposure and physical activity levels.

While this study's findings raise the possibility of a link between sunlight exposure and kidney cancer risk, "they clearly need to be replicated in other populations and in studies that use better estimates of long-term ultraviolet exposure and vitamin D intake," said Dr. Karami.


Story Source:

The above story is based on materials provided by American Cancer Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sara Karami, Paolo Boffetta, Patricia Stewart, Nathaniel Rothman, Katherine L. Hunting, Mustafa Dosemeci, Sonja I. Berndt, Paul Brennan, Wong-Ho Chow, and Lee E. Moore. Occupational sunlight exposure and risk of renal cell carcinoma. Cancer, Published Online: March 8, 2010 DOI: 10.1002/cncr.24939

Cite This Page:

American Cancer Society. "Occupational sunlight exposure reduces kidney cancer risk in men, study suggests." ScienceDaily. ScienceDaily, 8 March 2010. <www.sciencedaily.com/releases/2010/03/100308081742.htm>.
American Cancer Society. (2010, March 8). Occupational sunlight exposure reduces kidney cancer risk in men, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/03/100308081742.htm
American Cancer Society. "Occupational sunlight exposure reduces kidney cancer risk in men, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/03/100308081742.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins